Healixa Inc (OTC:EMOR) CEO Ian Parker published a letter to shareholders Wednesday that outlined the company’s goals for 2023, including uplisting the green technology company to a national exchange.
“During the course of 2022, Healixa has continued to expand its portfolio of ‘healing technologies,’ while simultaneously commercializing its PurelyRx digital health care eco-system and preparing the launch of our Global AquaDuct atmospheric water harvesting initiatives,” Parker wrote.
Looking to 2023, Parker’s goal is to expand Healixa’s PurelyRx customer base and recurring revenues, while also fortifying the platform with senior healthcare professionals.
READ: Healixa expands its advisory board with appointment of award-winning executive Satyajit Deb
Expanding the customer base would increase revenue, Parker noted, and the company plans to add additional values and benefits to the platform such as patient best pricing features, which would also expand revenue opportunities.
Meanwhile, Healixa expects to move Global AquaDuct into production and begin taking purchase orders and making deliveries. From there, the company can start working on other Global AquaDuct models designed for other markets and use cases.
Zooming out, Parker wants to see Healixa to a national stock exchange, and making the preparations to do so is a priority for 2023.
The full shareholder letter is available here.
Healixa is a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water generation and green-tech industries.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel